Cannabis Law Report

MAY 10, 2022

This is despite a limited number of high-quality clinical trials investigating the drug’s efficacy for this condition. Very few studies have also been done examining cannabis for the treatment of sleep disorders. Read their full article at . The findings were published today in Frontiers in Pharmacology.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

OCTOBER 27, 2021

patent, but its first for a form of psilocybin the company isn’t using in its clinical trials on treatment-resistant depression. Read full article [link]. This is Compass Pathways’ fourth U.S. As always we’re expecting challenges,” said Compass’s co-founder and president Lars Christian Wilde. “We

Clinical Trials 52

Clinical Trials Medicine Treatment Law 52

FloridaMarijuana.net

AUGUST 16, 2018

The Dementia Society of America attributes Dementia to rising healthcare costs as billions are spent each year for treatments and research. Pharmaceutical treatments for for Dementia often only target symptoms like pain or depression, but those medicines do not cure or prevent the disease.

Clinical Trials 184

Clinical Trials Marijuana Patients Pharmaceutical 184

Project CBD

MARCH 21, 2023

All but two of the 45 respondents said they’d consider cannabis as a treatment, with 29 seeking help for sleep disturbances, 27 for emotional complaints, 25 for functional disturbances, and nine for pain. Despite all this, there is a potential biological rationale for the treatment of tinnitus with cannabinoids, the authors explain.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Cannabis Law Report

DECEMBER 27, 2019

Virtual Clinical Trials transcend geographic, mobility and economic barriers. Clinical trials are medical research projects involving human participants. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Law Report

AUGUST 10, 2021

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. For example, the Tuskegee Syphilis Study, wherein Black men were deceived regarding their diagnosis and deprived appropriate treatment over the course of decades.

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

Canna Law Blog

NOVEMBER 27, 2021

Medicines and Healthcare Products Regulatory Agency for one of its DMT products for the treatment of major depressive disorder. In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinical trial this past summer. MDMA (Ecstasy) Nears FDA Approval for PTSD Treatment.

Therapy 87

Therapy Clinical Trials DEA Microdosing 87

Cannabis Law Report

OCTOBER 5, 2021

Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions. An evaluation of the therapeutic value, benefits and risks of methylenedioxymethamphetamine (MDMA) and psilocybin for the treatment of mental, behavioural or developmental disorders.

Treatment 52

Treatment Conditions Medicine Clinical Trials 52

MMJ Recs

NOVEMBER 20, 2023

This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. Epilepsy Management: CBD, in particular, has emerged as an effective treatment for epilepsy, especially in individuals with rare and severe forms of the condition.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Cannabis Law Report

MAY 31, 2022

In a previous article, we explored one potential current opportunity for entrepreneurs interested in psychedelics and mycelium— producing non-psychoactive mushroom supplements. Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

AUGUST 5, 2021

Psychedelics are quickly emerging as alternative methods of treatment for mental illnesses and neurodegenerative conditions — particularly in countries such as Canada. FULL DISCLOSURE: This is a paid article produced by Stockhouse Publishing. per cent to reach US$6.86 billion in 2027, up significantly from $2.07 billion in 2019.

Extraction 105

Extraction Clinical Trials Research and Development Pharmaceutical 105

Cannabis Law Report

MAY 28, 2022

We have been following the research and development of these medicines for psychiatric conditions such as PTSD and treatment-resistant depression. Read full article at. How does Husch Blackwell intend to assist or guide innovators in the psychedelics industry?

Research and Development 52

Research and Development Therapy Clinical Trials Legalization 52

CannaMD

JUNE 2, 2021

Non-uses were also asked what factors might cause them to consider adding medical marijuana to their treatment regime. More than 80% of survey respondents indicated strong interest in learning more information about a clinical trial, and more than half were interested in enrolling in a clinical trial.

Patients 105

Patients Clinical Trials Treatment Research and Development 105

Cannabis Law Report

AUGUST 6, 2021

In this article, we’ll tell you what some of the top health benefits of CBD products are: Mental Health Disorders. It’s well known that CBD can be very useful in the treatment of mental health disorders, such as anxiety and depression. Clinical trials have shown that small doses of CBD help people to manage their social anxiety.

CBD 105

CBD Wellness and Beauty Treatment Pharmaceutical 105

SpeedWeed

SEPTEMBER 17, 2021

The funding will allow MAPS Public Benefit Corporation (MAPS PBC) to activate a team to evaluate the scope of the lack of resources needed for TBI treatment. . Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. View original article.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

The Cannigma

FEBRUARY 2, 2021

This article was originally published on Analytical Cannabis and appears here with permission. . Of these consumers, over half said the drug had a beneficial clinical effect on their condition. Physicians should consider these aspects when advising their patients about treatment with medicinal cannabis.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Canna Law Blog

JANUARY 22, 2020

The company is also running a phase IIb clinical trial of its patented formulation, COMP360, which we covered in a blog post back in 2018. In that post, I explained how the Food and Drug Administration (FDA) approval process works and why this trial is so interesting and important. Psilocybin!

Clinical Trials 116

Clinical Trials Decriminalization Microdosing Food 116

FloridaMarijuana.net

AUGUST 15, 2018

Additionally, the ACPA reported on a clinical trial that suggests that inhaled cannabis may provide short-term relief from Neuropathy. More than ever, cannabis can aid in the treatment of chronic disease and as a supplement to other medical interventions and treatments.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

MMJ Recs

DECEMBER 28, 2023

In recent years, a significant shift has occurred in the perception of medical marijuana, transforming it from a controversial substance to a recognized and, in some places, a legal form of medical treatment. Epidiolex, a CBD-based medication, has even received FDA approval for the treatment of specific seizure disorders.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

SpeedWeed

AUGUST 11, 2021

Suicide among veterans is an urgent public health crisis, but it’s solvable if we invest in researching new treatments for pain, depression, and PTSD,” said Sisley in a press statement. Results of this study showed evidence of the pros and cons to cannabis as a treatment for PTSD patients. View original article.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

SpeedWeed

MAY 22, 2021

The US Food and Drug Administration (FDA) has just approved a new clinical trial that will allow therapists to legally use MDMA. For this Phase 1 trial, MAPS will recruit 150 therapists that are currently being trained to conduct MDMA-assisted therapy sessions for PTSD. . View original article.

Clinical Trials 52

Clinical Trials Therapy Legalization Research and Development 52

The Cannigma

JANUARY 24, 2021

This article was first published on Analytical Cannabis. The team at the University of Queensland soon noticed that one form of CBD was particularly adept at breaking down MRSA’s biofilms, the slimy structural supports that help the bacteria survive antibiotic treatments. It appears here with permission.

CBD 125

CBD Clinical Trials Treatment Pharmaceutical 125

Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. We are aware of clinical trials in that space, but not strong evidence.”. Read their full article at. The Guardian writes. of prescriptions were for sleep disorders.

Medicine 52

Medicine Clinical Trials Data Sleep 52

SpeedWeed

JULY 23, 2021

When you’re talking about wanting to do an actual clinical trial, you need a diversity of people that participate and one state just does not have the diversity of people that are required,” Towle said. It means] better research, and then that research will lead to better treatments with fewer side effects,” said Towle.

Clinical Trials 52

Clinical Trials Research and Development DEA Cannabinoids 52

Cannabis Law Report

MARCH 2, 2020

Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to Compass Pathways ‘ psilocybin therapy for treatment-resistant depression. First up, cannabis has now been scientifically validated as a treatment for two severe forms of childhood epilepsy (more on this in a moment). In 2018, the U.S.

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

Veriheal

MAY 3, 2022

Clinical Trial Sample Size. The trial was conducted with just 186 participants, which is far too small of a sample size to provide findings generalizable to the larger population. We’ll never know for certain whether this article was intentionally designed to scare potential MMJ patients away.

Research and Development 95

Research and Development Clinical Trials Consumption Patients 95

Cannabis Law Report

JULY 29, 2021

of their dry weight and it is not practical to obtain meaningful pure amounts of these compounds from the flesh of mushrooms, at a reasonable cost, to conduct clinical trials in humans and to commercialize these products. FDA approved guidelines for clinical studies. ” About Nova Mentis Life Science Corp.

Clinical Trials 105

Clinical Trials Conditions Packaging Events 105

Cannabis Law Report

FEBRUARY 28, 2022

Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. 1025, 1026 (2021) (reporting significant improvement of PTSD symptoms following treatment with MDMA in clinical trial); see also Alec J. Mitchell et al., Divito & Robert F. TIMES (Nov.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Since then, “ketamine clinics” have proliferated throughout the U.S., Id ; 21 CFR 312.1-10;

Law 105

Law Therapy Clinical Trials Research and Development 105

SpeedWeed

AUGUST 16, 2021

Oxford-based startup Beckley Psytech in the United Kingdom announced August 15 that it raised $80 million to ramp up clinical trials and research using a pharmaceutical formulation of ??5-MeO-DMT Clinical studies using psilocybin show huge potential to battle treatment-resistant depression, under the guidance of a therapist.

Research and Development 52

Research and Development Clinical Trials Treatment Conditions 52

SpeedWeed

SEPTEMBER 4, 2021

Titled “Proposed Adjustments to the Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2021,” the article specifically includes some major changes for cannabis and psilocybin. View original article.

DEA 52

DEA Research and Development Clinical Trials Extraction 52

Cannabis Law Report

AUGUST 28, 2022

This article will discuss the different cannabinoids and their effects on the body! These compounds have been shown to have a variety of medical applications, ranging from pain relief to the treatment of anxiety and depression. What is the future of cannabinoid research and treatment options?

Cannabinoids 52

Cannabinoids Trichome Treatment Clinical Trials 52

SpeedWeed

MARCH 30, 2021

Anthony Ordman is Honorary Medical Director of Integro Medical Clinics – one of the 20-plus private clinics to have emerged since the law change in 2018. He would like to see the registry opened up to the private sector and believes the restricted conditions available for treatment through the NHS will limit its effectiveness.

Data 52

Data Patients Clinical Trials Business 52

Healer

MARCH 26, 2021

This article was originally published in the Portland Press Herald. Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. March 19, 2021. Others aren’t so sure.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

The Cannigma

MAY 13, 2022

Over 10% of US adults have suffered from some degree of daily pain for at least three months, so the need for improved treatment is clear. There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. 12 Pinene had the ability to meditate chemical responses to inflammation in rodent trials.

Terpenes 111

Terpenes Strains Chronic Pain Clinical Trials 111

United Patients Group

JANUARY 8, 2023

Cannabis has been shown to be an effective treatment for a variety of conditions caused by bacteria, viruses and fungi. The ECS may be involved in a number of other diseases and conditions, as well as cancer treatment side effects such as nausea or loss of appetite. Cannabis has Antiviral, Antibacterial and Fungal Properties.

Blood Pressure 105

Blood Pressure Sleep Cannabinoids Clinical Trials 105

SpeedWeed

MARCH 18, 2021

Preliminary results from a long-awaited study indicate that cannabis appears to be a safe and well-tolerated treatment for patients managing post-traumatic stress disorder (PTSD), although researchers did not find strong signals of effectiveness. for the production of cannabis used in federally-regulated clinical trials.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40